{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:55:18Z","timestamp":1794027318140,"version":"4.8.0"},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T00:00:00Z","timestamp":1302825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Three aromatase inhibitors, namely anastrozole, letrozole and exemestane, which reduce circulating oestrogen, are used to treat breast cancer patients; the therapeutic use of such aromatase inhibitors is quickly increasing.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> We intended (i) to review aromatase inhibitor\u2010induced cutaneous adverse effects and (ii) to describe a recently observed case of cutaneous vasculitis triggered by exemestane.<\/jats:p><jats:p><jats:bold>Patients\/methods\u2002<\/jats:bold> The so\u2010far reported literature cases of aromatase inhibitor\u2010induced cutaneous adverse effects were analysed retrospectively. Especially, the clinical case of exemestane\u2010induced cutaneous vasculitis herein reported is unique, because such an observation has not yet been published in the literature.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Merely 12 cases of cutaneous adverse reactions induced by aromatase inhibitors, namely erythema nodosum (6), subacute cutaneous lupus erythematosus (1), cutaneous rashes (2), vasculitis (3, including the one described in this study), are reported in the literature. In fact, in the present case, cutaneous vasculitis was strictly related to exemestane.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> As aromatase inhibitors (e.g. exemestane) are increasingly incorporated into the treatment strategy of breast cancer patients, it is important to recognize possible cutaneous adverse effects. Specifically, with regard to cutaneous vasculitis, some patients might progress to severe vasculitis manifestations if the offending drug (e.g. exemestane) is not quickly stopped.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2010.03803.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T09:31:27Z","timestamp":1279618287000},"page":"596-598","source":"Crossref","is-referenced-by-count":31,"title":["Aromatase inhibitor\u2010induced skin adverse reactions: exemestane\u2010related cutaneous vasculitis"],"prefix":"10.1111","volume":"25","author":[{"given":"S","family":"Santoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CA","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Tognetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cortelazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ficarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"De Panfilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,4,15]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/107327480200900606"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.00594"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023246"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11745"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/030089160609200103"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-007-9518-7"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.023150"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.07.001"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08367.x"},{"key":"e_1_2_4_11_2","first-page":"1606","volume-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Gota CE","year":"2008"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.3322"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.dad.0000181109.54532.c5"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.2.155"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.18.3808"},{"key":"e_1_2_4_16_2","first-page":"6523","article-title":"Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1\/2 expression status","volume":"63","author":"Ellis MJ","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209685"},{"key":"e_1_2_4_18_2","first-page":"2807","article-title":"A comparison of letrozole and tamoxifen in postmenopausal woman with early breast cancer","volume":"353","author":"Th\u00fcrlimann B","year":"2005","journal-title":"N Engl J Med"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3282f1331f"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2010.03803.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2010.03803.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T17:24:24Z","timestamp":1697390664000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2010.03803.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,15]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1111\/j.1468-3083.2010.03803.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03803.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,15]]}}}